𝔖 Bobbio Scriptorium
✦   LIBER   ✦

107 A RANDOMISED CONTROLLED TRIAL OF MELOXICAM, A COX-2 INHIBITOR, TO PREVENT HEPATOCELLULAR CARCINOMA RECURRENCE AFTER INITIAL CURATIVE TREATMENT

✍ Scribed by Takami, Y.; Tateishi, M.; Ryu, T.; Wada, Y.; Saitsu, H.


Book ID
122018847
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
59 KB
Volume
58
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES